The role of botulinum toxin as a therapeutic agent is expanding rapidly in
otolaryngology. Botulinum toxin is a protease that blocks the release of ac
etylcholine from nerve terminals. Its effects are transient and nondestruct
ive, and largely limited to the area in which it is administered. These eff
ects are also graded according to dose, allowing for individualized treatme
nt of patients and disorders. Botulinum toxin has been used primarily to tr
eat disorders of excessive or inappropriate muscle contraction. In the fiel
d of otolaryngology, these include spasmodic dysphonia, oromandibular dysto
nia, and blepharospasm; vocal tics and stuttering; cricopharyngeal achalasi
a; various tremors and tics; hemifacial spasm; temporomandibular joint diso
rders; and a number of cosmetic applications. Botulinum toxin treatment has
recently begun to show some benefit in the control of pain from migraine a
nd tension headache. It may also prove useful in the control of autonomic d
ysfunction, as in Frey syndrome, sialorrhea, and rhinorrhea. In over 20 yea
rs of use in humans, botulinum toxin has accumulated a considerable safety
record, and in many cases represents relief for thousands of patients unaid
ed by other therapy.